scholarly journals Compliance of long-term nasal high flow oxygen treatment in COPD patients with chronic hypoxic failure

2017 ◽  
Vol 26 ◽  
pp. 71-71
Keyword(s):  
High Flow ◽  
Oxygen Treatment ◽  
Copd Patients ◽  
High Flow Oxygen

scholarly journals Weaning from mechanical ventilation with high flow oxygen therapy via tracheal cannula

2020 ◽  
pp. 1-6
Author(s):  
Kristijan Skok ◽  
Jerneja Golub ◽  
Damjana Kunej ◽  
Andreja Sinkovič ◽  
Andrej Markota
Keyword(s):  
Mechanical Ventilation ◽  
Ventilatory Support ◽  
High Flow ◽  
Weaning From Mechanical Ventilation ◽  
Hypoxemic Respiratory Failure ◽  
Case Presentation ◽  
Tracheal Cannula ◽  
High Flow Oxygen ◽  
High Flows

Introduction: Application of oxygen at high flows via nasal cannula can be used in patients with hypoxemic respiratory failure and to prevent reintubation. It is well tolerated by the patients and has been associated with lower mortality. However, there is very little data on the use of oxygen at high flows connected to tracheal cannula (HFOTC). Case presentation: We present two patients in whom weaning from mechanical ventilation was difficult and we decided to use HFOTC for weaning. Weaning from mechanical ventilation with HFOTC was successful in both patients and they tolerated long term (4 and 2 days, respectively) ventilatory support with HFOTC without adverse effects. Conclusions: HFOTC might be used during weaning from mechanical ventilation, however, more data is needed to determine the optimal use of this treatment option.

scholarly journals Efficacy and safety of nasal high-flow oxygen in COPD patients

2017 ◽  
Vol 17 (1) ◽  
Author(s):  
Helene Vogelsinger ◽  
Michael Halank ◽  
Silke Braun ◽  
Heinrike Wilkens ◽  
Thomas Geiser ◽  
...  
Keyword(s):  
High Flow ◽  
Efficacy And Safety ◽  
Copd Patients ◽  
High Flow Oxygen

scholarly journals Characteristics and outcome of patients set up on high-flow oxygen therapy at home

2019 ◽  
Vol 13 ◽  
pp. 175346661987979 ◽  
Author(s):  
Samuel Dolidon ◽  
Johann Dupuis ◽  
Luis-Carlos Molano Valencia ◽  
Mathieu Salaün ◽  
Luc Thiberville ◽  
...  
Keyword(s):  
Respiratory Failure ◽  
Median Survival ◽  
Oxygen Therapy ◽  
Airway Disease ◽  
High Flow ◽  
University Hospital ◽  
Hypoxemic Respiratory Failure ◽  
High Flow Oxygen ◽  
At Home

Background: High-flow oxygen therapy (HFOT) is increasingly used for acute respiratory failure. Few data support its use at home for the treatment of chronic respiratory failure. Our aim was to report the pattern of the use of long-term HFOT in our center and the outcome of patients setup on long-term HFOT. Methods: A retrospective monocentric study including all patients setup on long-term HFOT between January 2011 and April 2018 in Rouen University Hospital was carried out. Patients were divided into two groups, patients with hypoxemic respiratory failure treated with nasal HFOT (nHFOT) and tracheotomized patients treated with tracheal HFOT (tHFOT). Results: A total of 71 patients were established on long-term HFOT. Out of these 43 (61%) were included in the nHFOT group and 28 (39%) were included in the tHFOT group. In the nHFOT group, underlying respiratory diseases were interstitial lung disease ( n = 15, 35%), pulmonary hypertension ( n = 12, 28%), lung cancer ( n = 9, 21%), and chronic airway disease ( n = 7, 16%). In the tHFOT group, the number of admissions for exacerbation decreased by −0.78 per year (–2 to 0) ( p = 0.045). In total, 51 (72%) patients were discharged to their homes and 20 (28%) went to a post-acute re-enablement facility. Median survival following HFOT was 7.5 months. Survival was significantly lower in the nHFOT group with a median survival of 3.6 months whereas median survival was not reached in the tHFOT group ( p < 0.001). Monthly costs associated with home delivery of HFOT were €476 (296–533) with significant differences in costs between the nHFOT group of €520 (408–628) and costs in the tHFOT group of €296 (261–475) ( p < 0.001). Conclusions: The use of long-term HFOT allows very severe patients to be discharged at a reasonable cost from acute care facilities. The reviews of this paper are available via the supplementary material section.

scholarly journals A change from high-flow to titrated oxygen therapy in the prehospital setting is associated with lower mortality in COPD patients with acute exacerbations: an observational cohort study

2020 ◽  
Vol 19 (2) ◽  
pp. 76-82
Author(s):  
Lasse Paludan Bentsen ◽  
◽  
Annmarie Touborg Lassen ◽  
Ingrid Louise Titlestad ◽  
Mikkel Brabrand ◽  
...  
Keyword(s):  
Acute Exacerbation ◽  
Primary Outcome ◽  
Treatment Protocol ◽  
High Flow ◽  
Copd Patients ◽  
High Flow Oxygen ◽  
Acute Exacerbations ◽  
Before And After ◽  
Observational Cohort ◽  
Flow Group

Background: The aim of this study was to investigate 30-day mortality for COPD patients treated by ambulances in the period before and after implementation of a pre-hospital oxygen protocol. Methods: Prehospital High-flow oxygen was used from April to September 2012 and titrated oxygen from April to September 2013. Primary outcome was 30-day mortality. Results: 707 patients were included; 209 in the high-flow group and 498 in the titration group. Of these, 56 and 132 arrived with acute exacerbation (AE). Overall 30-day mortality was 11.5% vs. 9.4% (p=0.41), respectively. For patients with AE, it was 19.6% vs. 4.6% (p=0.001). Conclusion: Change of treatment protocol is associated with a lower 30-day mortality for patients registered with acute exacerbation, but not for all COPD patients.

Sign in / Sign up

Export Citation Format

Share Document